Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins laboratories work with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic, and labelling is accurate.
Eurofins is dedicated to delivering testing services that contribute to the health and safety of society and the planet, and to its corporate responsibility to protect the environment and ensure diversity, equity, and inclusion across the entire network of Eurofins companies.
Reporting to the Finance Director of Eurofins Japan, the Treasury, Fixed Assets and Tax Manager will be responsible for leading key finance processes, for providing technical guidance for the entire Finance team and pursuing transformational initiatives towards goal to become a “best in class” finance organization (transformation initiated in 2024, now largely advanced and to be fully completed by end of 2027).
Eurofins Japan NSC (National Service Center) is a company which provides Accounting, Tax, Payroll, Legal and Purchasing services to all businesses of Eurofins Japan Group. Eurofins Japan Group is an industry leader in the area of laboratory testing and is comprised of a diverse and dynamic business portfolio of 8 major business lines, close to 20 operating entities and about 1,200 employees with continued growth plans for the next few years, both organically and through acquisitions.
Specific scope of responsibilities includes, though not limited to, the following:
Treasury:
Fixed Assets:
Tax:
This position will enable candidate to:
Potential to develop and take more responsibili

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories.
Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.